VELZE 500
(Sodium Valproate & Valproic Acid Control Released Tablets)
Composition:
Each controlled release tablet contains:
Sodium Valproate I.P. 333 mg
Valproic Acid I.P. 145 mg
Excipients q.s.
Packaging:
10 × 10 Tablets
Description
VELZE 500 is a controlled-release combination of Sodium Valproate (333 mg) and Valproic Acid (145 mg), providing sustained anticonvulsant and mood-stabilizing effects. It acts by increasing GABA levels through inhibition of its degradation, while also blocking voltage-gated sodium channels and T-type calcium channels, leading to stabilization of neuronal activity and suppression of abnormal electrical discharges.
The controlled-release formulation ensures prolonged action and improved patient compliance with reduced dosing frequency. VELZE 500 is indicated for the management of epilepsy and bipolar disorder.
Indications:
- Epilepsy (generalized and partial seizures, including absence, tonic-clonic, and myoclonic seizures)
- Bipolar disorder (management of acute mania and mood stabilization)
Therapeutic Segment Positioning:
Anticonvulsants (Neurology)
Be the first to review “VELZE 500”
You must be logged in to post a review.







Reviews
There are no reviews yet.